Cramer's biotech bonanza: A zone free from oil pain

Cramer: Celgene has phenomenal pipeline
Mad Money’s Jim Cramer highlights winning biotech names out of the American Society of Hematology Annual Meeting.
As the market licks its wounds from the hideous decline in oil prices, Jim Cramer would like to remind investors that there is one leg of the industry that has no economic sensitivity whatsoever to the price of oil: biotechs. […]